Dr. Harbison is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6431 Fannin St
# Msb
Houston, TX 77030Phone+1 713-500-6714Fax+1 713-704-9301
Education & Training
- Duke University HospitalResidency, Internal Medicine/Pediatrics, 2002 - 2006
- McGovern Medical School at UTHealthClass of 2002
Certifications & Licensure
- TX State Medical License 2008 - 2026
- MI State Medical License 2006 - 2010
- NC State Medical License 2002 - 2006
Publications & Presentations
PubMed
- 130 citationsEffects of the Proteasome Inhibitor PS-341 on Apoptosis and Angiogenesis in Orthotopic Human Pancreatic Tumor XenograftsSteffan T. Nawrocki, Christiane J. Bruns, Matthew T. Harbison, Richard J. Bold, Bridget Sweeney Gotsch
Molecular Cancer Therapeutics. 2002-12-01 - 122 citationsEffect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing o...Christiane J. Bruns, Marissa Shrader, Matthew T. Harbison, Charles A. Portera, Carmen C. Solorzano
International Journal of Cancer. 2002-11-10 - 425 citationsBlockade of the Epidermal Growth Factor Receptor Signaling by a Novel Tyrosine Kinase Inhibitor Leads to Apoptosis of Endothelial Cells and Therapy of Human Pancreatic...Christiane J. Bruns, Carmen C. Solorzano, Matthew T. Harbison, Shutaro Ozawa, Rachel Tsan
Cancer Research. 2000-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: